Skip to Main Content

An official website of the United States government

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Cancer Genetic Markers of Susceptibility (CGEMS): Contribution of Breast Cancer Cases and Controls from PLCO Cancer Screening Trial

Datasets


Site: Misc

Inclusion Criteria:

  • All I-Arm Females
  • Supplemental Questionnaire
  • No prior history of any cancer prior to SQX
  • No confirmed or reported cancers
  • No rare cancers
  • Subjects are dead
  • No oral contraceptive use (BQ)
  • No current hormone use (SQX and BQ)
  • Has Biochemical Consent
  • Has Serum and Plasma Available
  • Has Perfect Serum and Plasma Available
  • Has Perfect T4/5 Serum and Plasma Available
  • Has Serum and Plasma Available at the same study year (Eligible)
  • Randomly selected 30 (Selected)

Match Ratio: Not Applicable

Match Technique: Not Applicable


Analytes:

  • C-Peptide
  • Insulin-like Growth Factor 1
  • Insulin-like Growth Factor 2
  • Insulin-like Growth Factor Binding Protein 3
  • Leptin

Number of Controls: 30